Only inpatient blood glucose monitoring system among leading hospital brands to use individually foil-wrapped test strips, helping reduce risk of test strip cross-contamination<br />
<br />
ABBOTT PARK, Ill. -- Abbott (NYSE: ABT) today announced that it has received U.S. Food and Drug Administration (FDA) clearance for its FreeStyle Precision Pro Blood Glucose and Beta-Ketone Monitoring System™, an advanced blood glucose monitoring system designed to address the key needs of hospital ...This story is related to the following:Test and Measuring InstrumentsSearch for suppliers of: Blood Chemistry Analyzers